07:00 , Jun 2, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Cystathionine β synthase (CBS)

Endocrine/metabolic disease INDICATION: Metabolic Mouse studies suggest CBS could help treat homocystinuria, in which deficiency of the enzyme can cause accumulation of homocysteine in serum and organs. In a mouse model of homocystinuria with non-lethal...
08:00 , Mar 3, 2014 |  BioCentury  |  Emerging Company Profile

CBS: Sniffing out cancer therapy

CBS Therapeutics Inc. is developing first-in-class inhibitors of cystathionine beta synthase that could synergize with existing therapies to treat both KRAS-mutant and wild-type metastatic colorectal cancer. Cystathionine beta synthase (CBS) is found in many cell...